Latest Sustainability News

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

Moonlight Resources has kicked off its ASX debut with promising gold drilling results at its Clermont project, confirming significant mineralisation and setting the stage for accelerated exploration.

Zinc of Ireland NL reported steady progress in its December 2025 quarter, highlighting sulphide intersections at its Mt Clere base metals project and ongoing geophysical work in Ireland’s Rathdowney Trend. The company ended the quarter with A$0.3 million cash on hand while actively evaluating new opportunities.

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

NT Minerals Limited reported a mixed cash flow quarter ending December 2025, with ongoing operational losses offset by strong investing inflows and a solid funding buffer. The company signals confidence in continuing operations despite tight liquidity.

Energy Technologies Limited has significantly improved its cash flow position in the December 2025 quarter, reducing cash outflows by over a third while raising additional debt funding to support working capital.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

Assetora Limited has strengthened its financial footing by securing over $4 million in capital commitments and resolving all legacy administration matters, positioning itself for a potential ASX reinstatement.

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.